This inventor holds 1 USPTO granted patent. Top assignee: The George Washington University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Eda Gjika: Innovator in Cancer Treatment Technology
Introduction
Eda Gjika is a prominent inventor based in Washington, DC, known for her groundbreaking work in cancer treatment technology. She has made significant contributions to the field of medical innovation, particularly in the area of sensitizing cancer cells to chemical treatments.
Latest Patents
Eda Gjika holds a patent for a method and system of sensitizing cancer cells to chemical treatment by plasma-based activation. This innovative approach involves using a cold atmospheric plasma jet to treat diseased tissues, such as areas with cancerous cells. The process includes ionizing a gas, such as helium, to create an initial plasma jet that is directed toward the affected area for a sufficient duration, typically around 10 seconds. This treatment sensitizes the cancer cells, enhancing the effectiveness of subsequent reactive treatments, such as H2O2 or TMZ.
Career Highlights
Eda Gjika is affiliated with Washington University, where she continues to advance her research and development in cancer treatment technologies. Her work is characterized by a commitment to improving patient outcomes through innovative medical solutions.
Collaborations
Eda collaborates with esteemed colleagues, including Dayun Yan and Michael Keidar, who contribute to her research efforts and the development of her patented technologies.
Conclusion
Eda Gjika's contributions to cancer treatment through her innovative patent demonstrate her dedication to advancing medical science. Her work not only highlights her expertise but also reflects the potential for new technologies to improve treatment outcomes for patients battling cancer.